For the motion: Endovascular Therapy is a better option for limb salvage in diabetic ulcer treatment Dr. Prasad Jetty Division of Vascular and Endovascular.

Slides:



Advertisements
Similar presentations
Infrapopliteal Sirolimus-Eluting Versus Bare Metal Stents for Critical Limb Ischemia: Long-Term Angiographic and Clinical Outcome in >100 Patients Dimitris.
Advertisements

Evolving Strategies in the Treatment of Peripheral Vascular Disease Ravish Sachar MD, FACC Wake Heart and Vascular.
Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Management of distal peripheral vascular disease Cheuk Kwan Yee, Queenie Tuen Mun Hospital.
The Cramping Leg Management of peripheral vascular disease
Hemodialysis access.
Monica Colvin-Adams, MD Assistant Professor of Medicine Advanced Heart Failure and Transplantation University of Minnesota Compassionate Allowances Outreach.
Diabetic Foot: A Surgical Look Mohammed Al-Omran, MD, MSc, FRCSC Assistant Professor & Consultant Vascular Surgery King Saud University.
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
When the blood vessels become obstructed, the tissues do not receive the necessary circulation to thrive. Over time, the area may become.
Epidemiology, Risk Factors, Diagnosis and Intervention of Abdominal Aortic Aneurysms By, Sultan O Al-Sheikh.
Superficial Femoral Artery Stents - Bare, Covered, or Drug-Coated – “The Data and The HYPE” Dennis F. Bandyk, MD Division of Vascular & Endovascular Surgery.
“Outpatient Arteriography and Arterial Intervention in Octogenarians. Is It Safe?” George G. Hartnell Baystate Medical Center Springfield, MA Safe at Any.
{ R. Diaz-Garcia MD, J. Bernardo MD Stem Cell Therapy for Patients with Critical Limb Ischemia: A Meta-analysis with Critical Limb Ischemia: A Meta-analysis.
Copyright ©2000 BMJ Publishing Group Ltd. Stratton, I. M et al. BMJ 2000; 321:
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
SIR-RFS AngioClub Ethan M. Dobrow, PGY-4 Maine Medical Center, Portland, Maine (The Freeman Hospital, Newcastle-Upon-Tyne, UK)
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
Aims To evaluate the technical and clinical outcome of percutaneous transluminal infra-popliteal angioplasties (PTIA) +/- stenting in a subgroup of patients.
MidAtlantic Vascular, LLC
Obesity Surgery : Is it only for losing weight ? Joint Hospital Surgical Grand Round Simon Chu Prince of Wales Hospital.
Achieving Acute Success and Durable Results with Complete Total Occlusion? Christopher J. Kwolek, MD FACS Harvard Medical School Division of Vascular and.
G. Rainey Williams Symposium September 30, 2005 CABG in the Elderly Patient: On or Off pump? A Single Center Experience R. Nathan Grantham, M.D.
Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
ACC/AHA 2006 guidelines on the management of PAD.
Trial Design Issues Associated with Evaluation of Distal Protection Devices in Diseased Saphenous Vein Grafts Bram D. Zuckerman, MD, FACC Medical Officer,
Dr C Raghu Interventional Cardiologist
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Medical Management of Claudication: Just Walk it Off!!
Faisal Alam Consultant Vascular & General Surgeon Royal Hospital.
Important questions As good or better ? Cost effective ? Overall, safer? Is it safe as a cancer operation? Can all surgeons do it? Compare to open surgery.
Samuel Thomas Rayburn, III MD Cardiovascular Surgeon Jack Stephens Heart Institute April 25, 2015.
Tomov, E. MD Department of Vascular Surgery, Tokuda Hospital Sofia.
The most important principle in treating foot ischemia in patients with diabetes is recognition that the etiology of this ischemia is macrovascular.
D.DELEANU, M.CROITORU BUCHAREST, ROMANIA. BTK Interventions ? BTK disease = claudication and CLI BTK interventions = CLI Main goal of CLI therapy = functional.
Tokuda Hospital Sofia Vascular Surgery and Angiology Department Dr. A. Daskalov, Assoc. Proff. V. Chervenkov.
CABG IN DIABETICS DR. SEYED SAEED FARZAM. Introduction Patients with diabetes mellitus Increased incidence of CAD More extensive disease at angiography.
The angiosome theory to guide revascularization for CLI
Richard F. Neville, MD Professor, Department of Surgery
Common femoral artery stenosis; is surgery still the best revascularization Richard F. Neville, MD Associate Director, INOVA Heart and Vascular Institute.
Diabetic Foot Limb Salvage: A Singapore Experience
The angiosome concept; open and endovascular treatment of CLI
Total Occlusion Study of Canada (TOSCA-2) Trial
Subclavian, Innominate & Vertebral Artery Treatment
The Missing Bifurcation
Hemodialysis access Sharifi 95.
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Treatment of iliac vein obstruction
Director: Center for Critical Limb Care Riverside Methodist Hospital
Crossing SFA-Popliteal Artery CTO’s
Excimer Laser Atherectomy for the Treatment of Infra-inguinal Peripheral Arterial Disease Bryan P Yan MD, Thomas J Kiernan MD, Vishal Gupta MD,
The Role of Interventional Treatment for The Failing Grafts
Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.
Open Repair of Ruptured Descending Thoracic and Thoracoabdominal Aortic Aneurysms in 100 Consecutive Cases Mario F. Gaudino, Christopher Lau, Monica Munjal,
מפגש מומחים: השמנה - טיפולים בריאטריים פרופ' זמיר הלפרן
Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative  Peter A. Soden, MD, Sara.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Surgical or endovascular revascularization in patients with critical limb ischemia: Influence of diabetes mellitus on clinical outcome  Florian Dick,
Enrique Criado, MD, Steven J. Burnham, MD, Ellis A
Michael S. Conte, MD  Journal of Vascular Surgery 
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass.
Division of Endovascular Interventions
Lower extremity bypass vs endovascular therapy for young patients with symptomatic peripheral arterial disease  Mauri J.A. Lepäntalo, MD, Rabih Houbballah,
Dr: Hamed Al-Ghamdi CONSULTANT VASCULAR SURGERY
Joseph G. Magnant, MD, Jack L. Cronenwett, MD, Daniel B
James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD 
From Theory to Practice: Creating a limb Preservation Center
Konstantinos Katsanos Joseph Mills Sigrid Nikol Jim Reekers
Presentation transcript:

For the motion: Endovascular Therapy is a better option for limb salvage in diabetic ulcer treatment Dr. Prasad Jetty Division of Vascular and Endovascular Surgery The Ottawa Hospital University of Ottawa

Endo vs open surgery for diabetic ulcers

p = 0.053

# 1. Patency Patency of angioplasty is worse than bypass in diabetic ulcer patients YES Angioplasty patency is worse!

# 1. Patency BUT ARE BYPASSES THAT GREAT??? 30-40% of bypasses develop stenoses with in 1 yr (Seminars of Vascular Surgery : ) 20-80% of successful patent bypasses have recurrent or persistent ulcers or wounds at 1 yr (Seminars of Vascular Surgery : ) Too late or bypass flow is not enough Non-ischemic ulcer Occluded bypass does not necessarily mean amputation or recurrent ulcer

# 1. Patency With good surveillance post angioplasty one can identify restenoses early and can easily and safely repeat the endovascular intervention and thus rival the patency rates of bypass procedures

# 1. Patency Are vasculopaths really looking for high 5 and 10 years patencies? 1 year mortality of patients with CLI is ~25% (American College of Cardiology, Canadian Cardiovascular Society 2005, 2009 updated guidelines)

# 1. Patency Therefore angioplasty may only need to be patent long enough until the patient dies from another cause or at least long enough to allow for ulcer healing, and can easily be repeated if it recurs

#2. Periprocedural mortality and morbidity ELDERLY RENAL FAILURE COPD SMOKER CORONARY DISEASE DIABETES DYSLIPIDEMIA HYPERTENSION OBESE

#2. Periprocedural mortality and morbidity Large prospective NSQIP analysis of >2500 patients revealed bypass has ~20% periprocedural complication rate, and 49% readmission rate at 6 mos (65% are bypass related) (LaMuraglia et al. Significant periooperative morbidity accompanies contemporary bypass surgery. Eu J Vasc Endo vasc Surg 2012; 43(5):549-55) Conte et al. Diabetic Revascularization – Do we have the answer Semin Vasc Surg 2012:25:

#2. Periprocedural mortality and morbidity 10-20% of bypass develop incisional wound complications metaanalysis 12% decline in ambulation and 15% loss of independent living post bypass surgery (LaMuraglia et al. Significant periooperative morbidity accompanies contemporary bypass surgery. Eu J Vasc Endo vasc Surg 2012; 43(5):549-55) Conte et al. Diabetic Revascularization – Do we have the answer Semin Vasc Surg 2012:25:

#2. Periprocedural mortality and morbidity Complications post angioplasty is ~2% (groin hematomas, pseudoaneurysms) and the patient is discharged the same day) (LaMuraglia et al. Significant periooperative morbidity accompanies contemporary bypass surgery. Eu J Vasc Endo vasc Surg 2012; 43(5):549-55) Conte et al. Diabetic Revascularization – Do we have the answer Semin Vasc Surg 2012:25:

#3. Multiple run-off vessels and distal pedal circulation

#4. Burning bridges? You will be burning bridges!

#4. Burning bridges? BASIL trial Concluded that survival is worse in pts who had endo-first failures followed by rescue bypass vs bypass-first pts

#4. Burning bridges? Flawed logic- Selection Bias Pts who failed angioplasty have selected themselves out as higher risk Problems with BASIL Extremely highly selective- only 1/10 patients randomized actually got the procedure they were suppose to get (does not represent the usual vascular population) Interventional radiologists did the endo procedures vs vascular surgeons Procedures done years ago - OUTDATED!! There are some good things about BASIL....

#4. Burning bridges? BASIL is very good in thai food

#5. Do all diabetic ulcers with vascular stenoses or occlusions need revascularization? Loss of sensation- prone to injury Demyelination and atrophy of intrinsic muscles Disruption of normal bony architecture Resultant abnormal pressure points Impaired immunity and delay in healing Micro vascular ischemia Macro vascular ischemia NO

#5. Not all diabetic ulcers with vascular stenoses or occlusions need revascularization some will heal with conservative therapy It is difficult to know exactly who will benefit Tendancy for vascular specialist to revascularize in the setting of concomittant vascular disease and therefore some patients maybe receiving revascularization when it may not be necessary.

#5. Not all diabetic ulcers with vascular stenoses or occlusions need revasculariztion An unnecessary bypass may be worse than an unnecessary angioplasty

Ask Uncle Google…

Thank you Division of Vascular and Endovascular surgery The Ottawa Hospital and University of Ottawa

Round 1

Rebuttal

TASC 2 Classification Type A: endovascular procedures are recommended Type B: endovascular procedures are recommended unless an open revascularization procedure (surgery) is required for other lesions in the same anatomic area Type C: open revascularization procedures are recommended. Endovascular procedures are only recommended in patients who have a low healing potential following surgical revascularization Type D: endovascular procedures are not recommended as first-line treatment

TASC guidelines are lesion-centric and do not emphasize the importance of weighing comorbid factors and life expectancy

#6. If you don’t embrace endovascular therapy someone else will It is crucial that the vascular surgeon embraces endo and leads innovation in the field otherwise we are going towards extinction

Evolution